HCW Biologics Inc (HCWB)
0.7374
-0.26
(-26.26%)
USD |
NASDAQ |
Jun 21, 16:00
0.9709
+0.23
(+31.67%)
After-Hours: 20:00
HCW Biologics Total Assets (Quarterly): 30.43M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.43M |
| December 31, 2023 | 28.51M |
| September 30, 2023 | 35.62M |
| June 30, 2023 | 39.48M |
| March 31, 2023 | 43.53M |
| December 31, 2022 | 46.81M |
| September 30, 2022 | 51.35M |
| Date | Value |
|---|---|
| June 30, 2022 | 47.41M |
| March 31, 2022 | 50.96M |
| December 31, 2021 | 53.51M |
| September 30, 2021 | 56.41M |
| June 30, 2021 | 13.03M |
| March 31, 2021 | 12.93M |
| December 31, 2020 | 15.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.93M
Minimum
Mar 2021
56.41M
Maximum
Sep 2021
37.53M
Average
41.51M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.69M |
| Shareholders Equity (Quarterly) | 8.741M |
| Debt to Equity Ratio | 0.9606 |
| Current Ratio | 0.4629 |
| Net Debt Paydown Yield | -0.60% |